Goldman Jonathan

Avalo Therapeutics, Inc. · Director

Goldman Jonathan is listed in public filings as director. This Goldman Jonathan insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Avalo Therapeutics, Inc. (AVTX). Investors use Goldman Jonathan's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Avalo Therapeutics, Inc.AVTX--3.2k sharesGrant / ExerciseMar 28, 2026Disclosure amount unavailable3.2k shares----

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Avalo Therapeutics, Inc.AVTX$08.2k sharesSellNov 14, 2025$117.6K8.2k shares$14.35--
Avalo Therapeutics, Inc.AVTX$81k8.2k sharesGrant / ExerciseNov 14, 2025$81.0K8.2k shares$9.88--
Avalo Therapeutics, Inc.AVTX$03.2k sharesSellNov 14, 2025$45.3K3.2k shares$14.30--
Avalo Therapeutics, Inc.AVTX$90k20.1k sharesGrant / ExerciseJun 17, 2025$89.8K20.1k shares$4.47--
Avalo Therapeutics, Inc.AVTX--3.2k sharesGrant / ExerciseMar 28, 2025Disclosure amount unavailable3.2k shares----
Avalo Therapeutics, Inc.AVTX$243k24.6k sharesGrant / ExerciseAug 13, 2024$243.0K24.6k shares$9.88--
Avalo Therapeutics, Inc.AVTX--9.5k sharesGrant / ExerciseAug 13, 2024Disclosure amount unavailable9.5k shares----